Atlas Trials

A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer

Clinical trial NCT00510250 · COMPLETED

Trial details

NCT number
NCT00510250
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cancer of the Cervix
Start date
2007-06-01
Primary completion
2010-09-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.